Sr. No. | Drug Name | Assay | Linearity Range | Matrix | Instrument |
---|
1 | Buspirone | Caco-2 | 0.0050 µM to 1.0099 µM | HBSS Buffer | API-4000 |
GI Stab | 5.0163 μM to 50.1228 μM | SGF and SIF Buffer | API-4000 |
Solubility | 0.5020 mg/mL to 40.1577 mg/mL | Buffer media | API-2000 |
2 | Doxepin | Caco-2 | 0.0010µM to 3.0046 µM | HBSS Buffer | API 4500 |
GI Stab | 0.0050 mg/mL to 1. 9984 mg/mL | SGF and SIF Buffer | API 2000 |
3 | Levorphanol Tartrate | Caco-2 | 0.0051 µM to 5.0070 µM | HBSS Buffer | API-3500 |
GI Stab | 1.0192 µM to 101.1060 µM | SGF and SIF Buffer | API-3500 |
Solubility | 1.0192 µM to 101.1060 µM | Buffer media | API-3500 |
4 | Imatinib | Caco-2 | 0.1052μM/mL to 29.5504μM/mL | HEPES Buffer in HBSS | API 4500 |
GI Stab | 10.0074 µM/mL to 501.2200 µM/mL | SGF and SIF Buffer | API 4000 |
5 | Dexamphetamine | Caco-2 | 0.1499 μM/mL to 174.5929 μM/mL | HBSS Buffer | API 4500 |
6 | Varenicline Tartrate | Caco-2 | 0.0030 μM to 2.9768 μM | HBSS Buffer | API 4500 |
GI Stab | 0.0010 mg/mL to 1.0011 mg/mL | SGF and SIF Buffer | API 2000 |
Solubility | 0.0010 mg/mL to 1.0011 mg/mL | Buffer media | API 2000 |
7 | Ramelteon | Caco-2 | 0.0113 µM to 5.0188 µM | HBSS Buffer | API-3500 |
Solubility | 10.0074 µM to 501.2200 µM | Buffer media | API-3500 |
8 | Valbenazine | Caco-2 | 0.0208 µM to 73.3549 µM | 2mM HEPES Buffer in HBSS buffer | API-4500 |
ɑ-dihydrotetrabenazine | 0.0117 µM to 41.1459 µM |
9 | Pimavanserin Tartrate | Caco-2 | 0.0039 µM to 4.5578 µM | 1 % BSA in HBSS Buffer | API 4500 |
10 | Cyclophosphamide | Caco-2 | 0.0200 µM to 50.5086 µM | HBSS Buffer | API 4500 |
Solubility | 0.0111 mg/mL to 1.1004 mg/mL | Buffer media | API 3500 |
11 | Hydroxychloroquine Sulfate | Caco-2 | 0.0250 μM to 10.0397 μM | HBSS Buffer | API 4500 |
GI Stab | 0.1003 mg/mL to 10.0489 mg/mL | SGF and SIF Buffer | API 4500 |
Solubility | 0.1003 mg/mL to 10.0489 mg/mL | Buffer media | API 4500 |
12 | Brivaracetam | Caco-2 | 0.1314 µM to 942.1759 µM | HBSS Buffer | API 3500 |
GI Stab | 0.0104 mg/mL to 1. 0220 mg/mL | SGF and SIF Buffer | API 3500 |
13 | Amitriptyline hydrochloride | Caco-2 | 0.1029 µM to 64.1001 µM | 1% BSA in HBSS Buffer | API-4500 |
14 | Guanfacine hydrochloride | Caco-2 | 0.0010 µM to 2.5607 µM | HBSS Buffer | API-4500 |
15 | Cevimeline | Caco-2 (i3 pharma) | 0.0050 µM to 10.0495 µM | HBSS Buffer | API-4500 |
16 | Dicyclomine | Caco-2 | 0.0215 µM to 25.1946 µM | 1% BSA in HBSS Buffer | API-4500 |
17 | Capecitabine | Caco-2 | 0.0202 µM to 10.0788 µM | HBSS Buffer | API-4000 |
GI Stab | 236.9059 μM to 9225.3932 μM | SIF Buffer | API-4000 |
Solubility | 0.0251 mg/mL to 2.0048 mg/mL | Buffer media | API-4000 |
18 | Propranolol hydrochloride | Caco-2 | 0.0205 µM to 20.1545 µM | HBSS Buffer | API-4000 |
GI Stab | 101.8333 μM to 1503.2541 μM | SGF and SIF Buffer | API-4000 |
Solubility | 0.0250 mg/mL to 0.4002 mg/mL | Buffer media | API-4000 |
19 | Lormetazepam | Caco-2 | 0.0010 µM to 0.2097 µM | HBSS Buffer | API-4500 |
GI Stab | 1.2392 µM to 20.0634 µM | SGF and SIF Buffer | API-4000 |
20 | Migalastat hydrochloride | Caco-2 | 0.0010 µM to 0.2580 µM | HBSS Buffer | API-4500 |
21 | Solriamfetol Hydrochloride | Caco-2 | of 0.0053 µM to 1.0539 µM | Methanol : Milli-Q water | API-4000 |
GI Stab | 15.1247 μM to 609.5724 μM | SGF and SIF Buffer | API-4000 |
22 | Lofexidine Hydrochloride | Caco-2 | 0.1016 nM to 20.3288 nM | HBSS Buffer | API-4500 |
GI Stab | 50.3205 nM to 603.8458 nM | SGF and SIF Buffer | API-4000 |
Solubility | 0.0136 mg/mL to 0.2630 mg/mL | Buffer media | API-4000 |